Telmisartan and Hydrochlorothiazide Tablets USP, 80 mg/25 mg, 30 Tablets, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot no 2, Phase-2, Pharma Zone, SEZ Pithampur, District Dhar, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc, USA, Mahwah, NJ 07430, NDC 68462-842-13.
Published August 17, 2022 · Recall initiated: June 29, 2022
Summary
FDA records drug Class II recall D-1305-2022, published August 17, 2022 and initiated June 29, 2022. Recalling firm: Glenmark Pharmaceuticals Inc., USA; Status: Terminated; Reported quantity: 72288 units; Lot: Lots 17210935 & 17210936., Exp Date 05/2023 Lot 17211206, Exp Date 06/2023 Lots 17211652, 17211655 & 17211658, Exp Date 08/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Container: Recall of these batches has been initiated due to complaints of difficult to open blister and tablet breaks while opening the blister .
What to do
Voluntary: Firm initiated · Letter
Get an email if TELMISARTAN AND HYDROCHLOROTHIAZIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- TELMISARTAN AND HYDROCHLOROTHIAZIDE
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Distributor
- nationwide
- UPC
- 0368462842133
- Lot
- Lots 17210935 & 17210936., Exp Date 05/2023 Lot 17211206, Exp Date 06/2023 Lots 17211652, 17211655 & 17211658, Exp Date 08/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATelmisartan and Hydrochlorothiazide Tablets USP, 80 mg/12.5 mg, 30 Tablets, Rx Only, Manufactured by: GlenmarkAugust 17, 2022
- FDALorazepam Injection, USP, 2mg/mL, 1 mL vial, 25 vials per carton, RX Only, Manufactured by West-WardAugust 17, 2022
- FDAAtivan Injection (lorazepam injection, USP), 2mg/mL, 1 mL vial, 25 vials per carton, RX Only, Manufactured byAugust 17, 2022
- FDAMerlin 2 PCS MER37000 programmer Model MER3400 softwareAugust 10, 2022
- FDAMerlin PCS 3650 programmer Model 3330 softwareAugust 10, 2022
- FDACustMbite, Model Number CBT-SRS-ULAugust 10, 2022
Questions about this recall
Was Telmisartan and Hydrochlorothiazide Tablets USP, 80 mg/25 mg, 30 Tablets, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot no 2, Phase-2, Pharma Zone, SEZ Pithampur, District Dhar, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc, USA, Mahwah, NJ 07430, NDC 68462-842-13. recalled?
Yes. FDA published recall D-1305-2022 on August 17, 2022. Reported hazard: Defective Container: Recall of these batches has been initiated due to complaints of difficult to open blister and tablet breaks while opening the blister .
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: TELMISARTAN AND HYDROCHLOROTHIAZIDE. UPC: 0368462842133.